Wugen

St Louis, United States

Wugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies

$115.0M raised

Aug 2025

Series C

Top Investors

Alpha Wave GlobalSands Capital VenturesFidelityIntermediate Capital GroupAbingworth

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Wugen raised?

Wugen has raised $115.0M in total funding. The most recent round was Series C. The last funding was announced in August 2025.

Who are Wugen's investors?

Wugen's investors include Alpha Wave Global, Sands Capital Ventures, Fidelity, Intermediate Capital Group, Abingworth.

Where is Wugen headquartered?

Wugen is headquartered in St Louis, United States.

What does Wugen do?

Wugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies

What stage is Wugen at?

Wugen is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 27, 2025.

MLA

"Wugen — Funding & Investors." VCBacked, August 27, 2025, https://www.vcbacked.co/company/wugen. Accessed June 4, 2026.

APA

VCBacked. (2025). Wugen — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/wugen

Wikipedia (cite web)

{{cite web |title=Wugen — Funding & Investors |url=https://www.vcbacked.co/company/wugen |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 27, 2025.